STERIS (STE)
(Delayed Data from NYSE)
$236.98 USD
-2.48 (-1.04%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $236.78 -0.20 (-0.08%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Steris (STE) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$250.00 | $265.00 | $230.00 | 4.40% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Steris comes to $250.00. The forecasts range from a low of $230.00 to a high of $265.00. The average price target represents an increase of 4.4% from the last closing price of $239.46.
Analyst Price Targets (6 )
Broker Rating
Steris currently has an average brokerage recommendation (ABR) of 1.86 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.86 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, four are Strong Buy, representing 57.14% of all recommendations. A month ago, Strong Buy represented 57.14%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.86 | 1.86 | 1.86 | 1.86 | 1.86 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/3/2024 | KeyBanc Capital Markets | Brett Fishbin | Strong Buy | Strong Buy |
8/8/2024 | Needham & Company | Michael Matson | Hold | Hold |
8/7/2024 | Stephens | Jacob Johnson | Strong Buy | Strong Buy |
5/9/2024 | Piper Sandler | Jason Bednar | Hold | Hold |
5/9/2024 | JMP Securities | David L Turkaly | Strong Buy | Strong Buy |
2/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.86 |
ABR (Last week) | 1.86 |
# of Recs in ABR | 7 |
Average Target Price | $250.00 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 72 of 253 |
Current Quarter EPS Est: | 2.12 |
STE FAQs
STERIS plc (STE) currently has an average brokerage recommendation (ABR) of 1.86 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for STERIS plc (STE) is $250.00. The current on short-term price targets is based on 3 reports.
The forecasts for STERIS plc (STE) range from a low of $230 to a high of $265. The average price target represents a increase of $5.49 from the last closing price of $236.98.
The current UPSIDE for STERIS plc (STE) is 5.49%
Based on short-term price targets offered by six analysts, the average price target for Steris comes to $250.00. The forecasts range from a low of $230.00 to a high of $265.00. The average price target represents an increase of 4.4% from the last closing price of $239.46.